Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population.

Sanath Thushara Kudagammana, Ruchira Ruwanthika Karunaratne, Thilini Surenika Munasinghe, Haputhanthirige Donna Wasana Samankumari Kudagammana
Author Information
  1. Sanath Thushara Kudagammana: Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, 20400 Sri Lanka. ORCID
  2. Ruchira Ruwanthika Karunaratne: Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, 20400 Sri Lanka.
  3. Thilini Surenika Munasinghe: Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, 20400 Sri Lanka.
  4. Haputhanthirige Donna Wasana Samankumari Kudagammana: Department of Medical Laboratory Sciences, Faculty of Allied Health sciences, University of Peradeniya, Peradeniya, Sri Lanka.

Abstract

BACKGROUND: Childhood pneumonia continues to be a disease that causes severe morbidity and mortality among children mainly in South-East Asia and Africa though it is not so in the developed world. Pneumonia accounts for 16% of all deaths of children under 5 years old in the world, killing nearly one million children in 2015. In Sri Lanka, there were 21,000 reported cases of pneumonia in 2006, 40% were in the age group of less than 4 years.
METHODS: This was a retrospective study done on the children aged 1 month to 14 years who were admitted to the Professorial Paediatric unit of Teaching Hospital, Peradeniya between 1st of March 2016 and 30th of July 2017 fulfilling diagnostic criteria for community-acquired pneumonia. Data including diagnosis, clinical details, management details and other relevant data were collected from patient records by using a data collection sheet.
RESULTS: In this study, 48% of 127 patients admitted with community-acquired pneumonia had bronchopneumonia. About 2/3 of the patients neededa secondline of intravenous antibiotics while 51/ 127 needed care in the high dependency unit with supplemental oxygen. No mortality was observed in the group.
CONCLUSIONS: Community- acquired paediatric pneumonia has a significant associated morbidity but not mortality in the studied population. The need for the second-line treatment with intravenous antibiotics in a significant proportion of patients may indicate a high degree of antibiotic resistance. Introduction of national antibiotic policy will help the cause.

Keywords

References

  1. Thorax. 2001 Dec;56 Suppl 4:IV1-64 [PMID: 11713364]
  2. BJOG. 2011 Sep;118 Suppl 2:78-87 [PMID: 21951505]
  3. Thorax. 2002 May;57(5):438-41 [PMID: 11978922]
  4. PLoS One. 2017 Jan 27;12(1):e0170787 [PMID: 28129377]
  5. Thorax. 2011 Oct;66 Suppl 2:ii1-23 [PMID: 21903691]
  6. Lancet Glob Health. 2019 Jan;7(1):e47-e57 [PMID: 30497986]
  7. Clin Infect Dis. 2011 Oct;53(7):e25-76 [PMID: 21880587]
  8. Bull World Health Organ. 2004 Dec;82(12):895-903 [PMID: 15654403]
  9. Pneumonia (Nathan). 2016 Aug 22;8:14 [PMID: 28702293]
  10. Klin Padiatr. 2005 Jul-Aug;217(4):211-9 [PMID: 16032546]
  11. Int J Epidemiol. 2003 Dec;32(6):1041-51 [PMID: 14681271]

Word Cloud

Created with Highcharts 10.0.0pneumoniachildrenmortalitypatientsacquiredmorbidityworldgroupstudyadmittedPaediatricunitcommunity-acquireddetailsdata127intravenousantibioticshighpaediatricsignificantpopulationantibioticCommunityBACKGROUND:ChildhoodcontinuesdiseasecausessevereamongmainlySouth-EastAsiaAfricathoughdevelopedPneumoniaaccounts16%deaths5 yearsoldkillingnearlyonemillion2015SriLanka21000reportedcases200640%ageless4 yearsMETHODS:retrospectivedoneaged1 month14 yearsProfessorialTeachingHospitalPeradeniya1stMarch201630thJuly2017fulfillingdiagnosticcriteriaDataincludingdiagnosisclinicalmanagementrelevantcollectedpatientrecordsusingcollectionsheetRESULTS:48%bronchopneumonia2/3neededasecondline51/neededcaredependencysupplementaloxygenobservedCONCLUSIONS:Community-associatedstudiedneedsecond-linetreatmentproportionmayindicatedegreeresistanceIntroductionnationalpolicywillhelpcauseexperiencepneumococcalvaccine-naivePneumococcal

Similar Articles

Cited By